Carrier-mediated membrane transport of folates in mammalian cells

Annual Review of Nutrition

Volumn 19, Issue , 1999, Pages 91-122

  Sirotnak, F M ^a   Tolner, Berend ^b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Kinetics; Multiplicities; RFC 1 gene expression; Structural specificity

Indexed keywords

FOLIC ACID;

ACTIVE TRANSPORT; ANIMAL CELL; CELL MEMBRANE TRANSPORT; CELL PROLIFERATION; GENE EXPRESSION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0032807982     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.19.1.91     Document Type: Review

References (130)

1. 1. Anderson RG, Kamen BA, Rothberg KG, Lacy SW. 1992. Photocytosis: sequestration and transport of small molecules by caveolae. Science 255:410-11
2. 2. Antony AC, Kane MA, Portillo RM, Elwood PC, Kolhouse JF. 1985. Studies of the role of a particulate folate binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J. Biol. Chem. 260:14911-17
3. 3. Antony AC, Utley C, Van Horne KC, Kolhouse JF. 1981. Isolation and characterization of a folate receptor from human placenta. J. Biol. Chem. 256:9684-92
4. 4. Barrueco JR, O'Leary DF, Sirotnak FM. 1992. Facilitated transport of methotrexate polyglutamates into lysosomes derived form S180 cells. Further characterization and evidence for a simple mobile carrier system with broad specificity for homo-or heteropeptides bearing a C-terminal glutamyl moiety. J. Biol. Chem. 267:19986-91
5. 5. Barrueco JR, O'Leary DF, Sirotnak FM. 1992. Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. Definition of a two-step process limited by mediated lysosomal permeation of polyglutamates and activating reduced sulfhydryl compounds. J. Biol. Chem. 267:15356-61
6. 6. Barrueco JR, Sirotnak FM. 1991. Evidence for facilitated transport of methotrexate polyglutamates into lysosomes derived form S180 cells. Basic properties and specificity for polyglutamate chain length. J. Biol. Chem. 266:11732-37
7. 7. Blakely RL. 1964. Pteridines in the metabolism of purines, pyrimidines and their derivatives. In The Biochemistry of Folic Acid and Related Pteridines, ed. A Neuberger, EL Tatum, pp. 219-60. Amsterdam: Elsevier North Holland. 517 pp.
8. 8. Bobzien WF III, Goldman ID. 1972. The mechanism of folate transport in rabbit reticulocytes. J. Clin. Invest. 51:1688-96
9. 9. Branda RF, Anthony BK. 1979. Evidence for transport of folate compounds by a specialized erythrocyte membrane system. J. Lab. Clin. Med. 94:354-60
10. 10. Branda RF, Anthony BK, Jacob HS. 1978. The mechanism of 5-methyltetrahydrofolate transport by human erythrocytes. J. Clin. Invest. 61:1270-75
11. 11. Brigle KE, Spinella MJ, Sierra EE, Goldman ID. 1995. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 marine leukemia cell line. J. Biol. Chem. 270:22974-79
12. 12. Brigle KE, Spinella MJ, Sierra EE, Goldman ID. 1997. Organization of the murine reduced folate carrier gene and identification of variant splice forms. Biochim. Biophys. Acta 1353:191-98
13. 13. Chan FP, Williams FM, Rogers KA, Flintoff WF. 1995. Chromosomal localization of the reduced folate transporter gene (SLC19A1) in Chinese hamster ovary cells. Cytogenet. Cell Genet. 71(2):148-50
14. 14. Chello PL, Sirotnak FM, Dorick DM. 1980. Alterations in the kinetics of methotrexate transport during growth of L1210 murine leukemia cells in culture. Mol. Pharmacol. 18:274-80
15. 15. Chello PL, Sirotnak FM, Dorick DM, Donsbach RC. 1977. Therapeutic relevance of differences in structural specificity of the transport systems for folate analogs in L1210 tumor cells and in isolated murine intestinal epithelial cells. Cancer Res. 37:4297-303
16. 16. Chello PL, Sirotnak FM, Wong E, Kisliuk RL, Gaumont Y, Combepine G. 1982. Further studies of stereospecificity at carbon 6 for membrane transport of tetrahydrofolates. Diastereoisomers of 5-methyltetrahydrofolate as competitive inhibitors of transport of methotrexate in L1210 cells. Biochem. Pharmacol. 31: 1527-30
17. 17. Chen C-P, Wagner C. 1975. Folate transport in choroid plexus. Life Sci. 16:1571-82
18. 18. Chiao JH, Roy K, Tolner B, Yang C-H, Sirotnak FM. 1997. RFC-1 gene expression regulates folate absorption in mouse small intestine. J. Biol. Chem. 272:11165-70
19. 19. Chiao JH, Yang C-H, Roy K, Pain J, Sirotnak FM. 1995. Ligand directed immunoaffinity purification and properties of the one-carbon, reduced folate transporter. J. Biol. Chem. 270:29698-704
20. 20. Corin RE, Haspel HE, Sonenberg M. 1984. Transport of the folate compound methotrexate decreases during differentiation of murine erythroleukemia cells. J. Biol. Chem. 259:206-11
21. 21. Cybulski RL, Fisher RR. 1981. Uptake of oxidized folates by rat liver mitochondria. Biochim. Biophys. Acta 646:329-33
22. 22. Dembo M, Sirotnak FM. 1984. Membrane transport of folate compounds in mammalian cells. See Ref. 98a, pp. 173-214
23. 23. Divekar AY, Vaidya NR, Braganca BM. 1967. Active transport of aminopterin in Yoshida sarcoma cells. Biochim. Biophys. Acta 135:927-36
24. 24. Dixon KH, Lanpher BC, Chiu J, Kelly K, Cowan KH. 1994. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J. Biol. Chem. 269:17-20
25. 25. Egan MG, Sirlin S, Rumberger BG, Garrow TA, Shane B, Sirotnak FM. 1995. Rapid decline in folylpolyglutamate synthetase activity and gene expression during maturation of HL-60 cells. Nature of the effect, impact on folate compound polyglutamate pools, and evidence for programmed down-regulation during maturation. J. Biol. Chem. 270:5462-68
26. 26. Eilam Y, Stein WD. 1974. Kinetic studies of transport across red cell membranes. Methods Membr. Biol. 2:283-354
27. 27. Eisenberg DE, Schwarz M, Komaromy M, Wall R. 1984. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179:125-42
28. 28. Fan J, Vitols KS, Huennekens FM. 1991. Biotin derivatives of methotrexate and folate. Synthesis and utilization for affinity purification of two membrane-associated folate transporter from L1210 cells. J. Biol. Chem. 266:14862-65
29. 29. Flintoff WF, Nagaines CR. 1983. Transport of methotrexate in Chinese hamster ovary cells: a mutant defective in methotrexate uptake and cell binding, Arch. Biochem. Biophys. 223:433-40
30. 30. Galivan J. 1979. Transport and metabolism of methotrexate in normal and resistant cultured rat hepatoma cells. Cancer Res. 39:735-43
31. 31. Galivan J. 1980. Membrane characteristics of primary hepatocyte cultures and a stable hepatocarcinoma cell line. Ann. NY Acad. Sci. 349:332-45
32. 32. Galivan J. 1980. Membrane characteristics of primary hepatocyte cultures and a stable hepatocarcinoma cell line. Ann. NY Acad. Sci. 349:332-45
33. 33. Galivan J. 1981. 5-Methyltetrahydrofolate transport by hepatoma cells and methotrexate-resistant sublines in culture. Cancer Res. 41:1757-62
34. 34. Galivan J. 1981. Transport of methotrexate by primary culture of rat heptacytes: stimulation of uptake in vitro by the presence of hormones in the medium. Arch. Biochem. Biophys. 206:113-21
35. 35. Gewirtz DA, White JC, Randolph JR, Goldman ID. 1980. Transport, binding and polyglutamylation of methotrexate in freshly isolated rat hepatocytes. Cancer Res. 40:573-78
36. 36. Goldman ID. 1971. A model system for the study of heteroexchange diffusion: methotrexate folate interactions L1210 leukemia and Ehrlich ascites tumor cells. Biochim. Biophys. Acta 233:624-34
37. 37. Goldman ID. 1971. The characteristics of membrane transport of amethopterin and the naturally occurring folates. Ann. NY Acad. Sci. 186:400-22
38. 37a. Goldman ID, ed. 1986. Membrane Transport of Antineoplastic Agents. Int. Encyl. Pharmacol. Ther., Vol. 118. Oxford/New York: Pergamon
39. 38. Goldman ID, Matherly LH. 1986. The cellular pharmacology of methotrexate. See Ref. 37a, pp. 283-302
40. 39. Gong M, Yess J, Connolly T, Ivy SP, Ohnuma T, et al. 1997. Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line. Blood 89:2494-99
41. 40. Harrap KR, Hill BT, Furness ME, Hart LI. 1971. Sites of action of amethopterin: intrinsic and acquired drug resistance. Ann. NY Acad. Sci. 186:312-24
42. 41. Henderson GB, Hughes TR, Saxena M. 1995. Distinct systems mediate the unidirectional efflux of methotrexate and cholate in human CCRF-CEM cells. Arch. Biochem. Biophys. 316:77-82
43. 42. Henderson GB, Strauss BP. 1990. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate resistant L1210 cells. Cancer Res. 50:1709-14
44. 43. Henderson GB, Tsuji JM, Kumar HP. 1988. Mediated uptake of folate by a high-affinity binding protein in sublines of L1210 cells adapted to nanomolar concentrations of folate. J. Membr. Biol. 101:247-58
45. 44. Henderson GB, Zevely EM. 1981. Anion exchange mechanism for transport of methotrexate in L1210 cells. Biochem. Biophys. Res. Commun. 99:163-69
46. 45. Henderson GB, Zevely EM. 1983. Structural requirements for anion substrates of the methotrexate transport system in L1210 cells. Arch. Biochem. Biochem. 221:438-46
47. 3H] methotrexate. J. Biol. Chem. 259:4558-62
48. 47. Hopp TP, Woods KR. 1981. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. USA 78:3824-28
49. + and pH dependence of 5-methyltetrahydrofolic acid and methotrexate transport in freshly isolated hepatocytes. Biochim. Biophys. Acta 1023:47-55
50. 49. Horne DW, Briggs WT, Wagner C. 1976. A functional active transport system for methotrexate in freshly isolated hepatocytes. Biochem. Biophys. Res. Commun. 68:70-76
51. 50. Horne DW, Briggs WT, Wagner C. 1978. Transport of 5-methyltetrahydrofolic and folic acid in freshly isolated hepatocytes. J. Biol. Chem. 253:3529-35
52. 51. Horne DW, Holloway RS, Said HM. 1992. Uptake of 5-formyltetrahydrofolate in isolated rat liver mitochondria is carrier-mediated. J. Nutr. 122:2204-9
53. 52. Horne DW, Reed KA. 1992. Transport of methotrexate in basolateral membrane vesicles from rat liver. Arch. Biochem. Biophys. 298:121-28
54. 53. Horne DW, Reed KA, Hoefs J, Said HM. 1993. 5-Methyltetrahydrofolic transport in basolateral membrane vesicles from human liver. Am. J. Clin. Nutr. 58:80-84
55. 54. Horne DW, Reed KA, Said HM. 1992. Transport of 5-methyltetrahydrofolate in basolateral membrane vesicles from rat liver. Am. J. Physiol. 262:G150-58
56. 55. Huennekens FM, Vitol KS, Suresh MR, Henderson GB. 1981. Transport of folate compounds in L1210 cells: components and mechanisms. In Molecular Actions and Targets of Chemotherapeutic Agents, ed. AC Sortorelli, JS Lazo, JR Bertino, pp. 333-46. New York: Academic
57. 56. Jackson RC, Hart LI, Harrap KR. 1976. Intrinsic resistance to cultured mammalian cells in relation to the inhibition kinetics of their dihydrofolate reductase. Cancer Res. 36:1991-97
58. 57. Jansen G, Westerhof GR, Jarmuszewski MJ, Kathmann I, Rijksen G, Schornagel JH. 1990. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J. Biol. Chem. 265:18272-77
59. 58. Kamen BA, Capdevila A. 1986. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc. Natl. Acad. Sci. USA 83:5983-87
60. 59. Kisliuk RL. 1984. The biochemistry of folates. See Ref. 98a, pp. 1-55
61. 60. Kool M, de Haas M, Scheffer GL, Scheper RJ, Van Eijk MJ, et al. 1997. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance associated protein gene (MRP1) in human cancer cell lines. Cancer Res. 57:3537-47
62. 61. Kotyk A, Janacek K. 1975. Kinetic aspects. Cell Membrane Transport, pp. 29-189. New York/London: Plenum
63. 62. Kumar CK, Moyer MP, Dudeja PK, Said HM. 1997. A protein-tyrosine kinase-regulated, pH dependent, carrier-mediated uptake system for folate in human normal colonic epithelial cell line NCM460. J. Biol. Chem. 272:6226-31
64. 63. Kyte J, Dolittle RF. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-32
65. 64. Lapenta V, Sossi V, Gosset P, Vayssettes C, Vitali T, et al. 1998. Construction of a 2.5-Mb integrated physical and gene map of distal 21q22.3. Genomics 49:1-13
66. 65. Lee H-C, Shoda R, Krall JA, Foster JD, Selhub J, Rosenberry TL. 1992. Folate binding protein from kidney brush border membranes contains components characteristic of a glycoinositol phospholipid anchor. Biochemistry 31:3236-43
67. 66. Luhrs CA, Pitiranggon P, da Costa M, Rothenberg SP, Slomiany BL, et al. 1987. Purified membrane and soluble folate binding proteins from cultured KB cells have similar amino acid compositions and molecular weights but differ in fatty acid acylation. Proc. Natl. Acad. Sci. USA 84:6546-49
68. 67. Masuda M, Fizuka Y, Yamazaki M, Nishigaki R, Kato Y, et al. 1997. Methotrexate is excreted into bile by canicular multispecific organic anion transporter in rats. Cancer Res. 57:3506-10
69. 68. Matherly LH, Angeles SM. 1994. Role of N-glycosylation in the structure and function of the methotrexate membrane transporter from CCRF-CEM human lymphoblastic leukemia cells. Biochem. Pharmacol. 47:1094-98
70. 69. Matherly LH, Angeles SM, Czajkowski CA. 1992. Characterization of transport mediated methotrexate resistance in human tumor cells with antibodies to the membrane carrier for methotrexate and tetrahydrofolate cofactors. J. Biol. Chem. 267:23253-60
71. 70. Matherly LH, Czajkowski CA, Angeles SM. 1991. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res. 51:3420-26
72. 71. Moccio DM, Sirotnak FM, Samuels LL, Ahmed T, Yagoda A, et al. 1984. Similar specificity of membrane transport for folate analogues and their metabolites by murine and human tumor cells: a clinically directed laboratory study. Cancer Res, 44:352-57
73. 72. Moscow JA, Gong M, He R, Sgagias MK, Dixon KH, et al. 1995. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 55:3790-94
74. 73. Murray RC, Williams FMR, Flintoff WF. 1996. Structural organization of the reduced folate carrier gene in Chinese hamster ovary cells. J. Biol. Chem. 32:19174-79
75. 74. Nguyen TT, Dyer DL, Dunning DD, Rubin SA, Grant KE, Said HM. 1997. Human intestinal folate transport: cloning, expression and distribution of complementary RNA. Gastroenterology 112: 783-91
76. 75. Niethammer D, Jackson RC. 1975. Changes of molecular properties associated with the development of resistance against methotrexate in human lymphoblastoid cells. Eur. J. Cancer 11:845-54
77. 76. Padgett RA, Grabowski PJ, Konarska MM, Seile S, Sharp PA. 1986. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55:1119-50
78. 77. Persson B, Argos P. 1996. Topology prediction of membrane proteins. Protein Sci. 5:363-71
79. 78. Prasad PD, Ramamoorthy S, Leibach FH, Ganapathy V. 1995. Molecular cloning of the human placental folate transporter. Biochem. Biophys. Res. Commun. 206:681-87
80. 79. Price EM, Freisheim JH. 1987. Photoaffinity analogues of methotrexate as folate antagonist binding probes. 2. Transport studies, photoaffinity labeling and identification of the membrane carrier protein for methotrexate from murine L1210 cells. Biochemistry 26:4757-63
81. 80. Ratnam M, Freisheim JH. 1992. Proteins involved in the transport of folates and antifolates by normal and neoplastic cells. In Folate Metabolism in Health and Disease, ed. MF Picriano, pp. 91-120. New York: Wiley-Liss
82. 81. Rehn M, Hintikka E, Pihlajaniemi T. 1996. Characterization of the mouse gene for the alpha-1 chain of type XVIII collagen (COLI8AI) reveals that the three variant N-terminal polypeptide forms are transcribed from two widely separated promoters. Genomics 32:436-46
83. 82. Roy K, Chiao JH, Spengler BA, Tolner B, Yang CH, et al. 1998. Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter. Cancer Genet. Cytogenet. 105(1):29-38
84. 83. Roy K, Tolner B, Chiao JH, Sirotnak FM. 1998. A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells. J. Biol. Chem. 273:2526-31
85. 3H-methotrexate by rabbit kidney slices. Cancer Res. 27:553-57
86. 85. Rubin R, Owens E, Rall D. 1968. Transport of methotrexate by the choroid plexus. Cancer Res. 28:689-94
87. 86. Said HM, Nguyen TT, Dyer DL, Cowan KH, Rubin SA. 1996. Intestinal folate transport: identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA. Biochem. Biophys. Acta Biomembr. 1281:164-72
88. 87. Saxena M, Henderson GB. 1998. ATP-dependent efflux of 2,4-dinitrophenyl-S-glutathione. Properties of two distinct transport systems in inside-out vesicles from L1210 cells and a variant subline with altered efflux of methotrexate and cholate. J. Biol. Chem. 270:5312-19
89. 88. Schilsky RL, Bailey BD, Chabner BA. 1981. Characteristics of membrane transport of methotrexate by cultured human breast cancer cells. Biochem. Pharmacol. 30:1537-42
90. 89. Schlemmer SR, Sirotnak FM. 1992. Energy dependent efflux of methotrexate in L1210 leukemia cells. Evidence for the role of an ATPase obtained with inside-out plasma membrane vesicles. J. Biol. Chem. 267:14746-47
91. 90. Schuetz JD, Matherly LH, Westin EH, Goldman ID. 1988. Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line. J. Biol. Chem. 263: 9840-47
92. 91. Selhub J, Dhar GJ, Rosenberg IH. 1986. Gastrointestinal absorption of antifolates. See Ref. 37a, pp. 147-56
93. 92. Selhub J, Rosenberg IH. 1978. Demonstration of high affinity folate binding activity associated with the brush border membranes of rat kidney. Proc. Natl. Acad. Sci. USA 75:3090-93
94. 93. Selhub J, Rosenberg IH. 1981. Folate transport in isolated brush-border membrane vesicles from rat intestine. J. Biol. Chem. 256:4489-93
95. 94. Sierra EE, Brigle KE, Spinella MJ, Goldman ID. 1997. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Biochem. Pharmacol. 53:223-31
96. 95. Sipos L, von Heijne G. 1993. Predicting the topology of eukaryotic membrane proteins. Eur. J. Biochem. 213(3): 1333-40
97. 96. Sirotnak FM. 1985. Obligate genetic expressing in tumor cells of a fetal membrane property mediating folate transport: biological significance and implications for improved therapy of human cancer. Cancer Res. 45:3992-4000
98. 97. Sirotnak FM, Chello PL, Mocio DM, Kisliuk RL, Combepine G, et al. 1979. Stereospecificity at carbon 6 of formyltetrahydrofolate as a competitive inhibitor of transport and cytotoxicity of methotrexate in vitro. Biochem. Pharmacol. 28:2993-97
99. 98. Sirotnak FM, Donsbach RC. 1976. Kinetic correlates of methotrexate transport and therapeutic responsiveness in murine tumors. Cancer Res. 36:1151-58
100. 98a. Sirotnak FM, Ensiminger WD, Burchall JJ, Montgomery JA, eds. 1984. Folate Antagonists as Therapeutic Agents. Vol. I. New York: Academic
101. 99. Sirotnak FM, Goutas LJ, Jacobsen DM, Mines L, Barrueco JR, et al. 1987. Carrier-mediated transport of folate compounds in L1210 cells: initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyl tetrahydrohomofolate in the presence of physiological anions. Biochem. Pharmacol. 36:1659-67
102. 100. Sirotnak FM, Goutas LJ, Mines LS. 1985. Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo. Cancer Res. 45:4732-34
103. 101. Sirotnak FM, Jacobson DM, Yang C-H. 1986. Alteration of folate analogue transport following induced maturation of HL-60 leukemia cells. Early decline in mediated influx relationship to commitment and functional dissociation of entry and exit routes. J. Biol. Chem. 261:11150-55
104. 102. Sirotnak FM, Moccio DM, Goutas LJ, Kelleher LE, Montgomery JA. 1982. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine. Cancer Res. 42:924-28
105. 103. Sirotnak FM, Moccio DM, Yang C-H. 1984. Similar characteristics of folate analogue transport in vitro in contrast to varying dihydrofolate reductase levels in epithelial cells at different stages of maturation in mouse small intestine. Cancer Res. 44:5204-11
106. 104. Smart EJ, Foster DC, Ying YS, Kamen BA, Anderson RG. 1994. Protein kinase C activators inhibit receptor-mediated photocytosis by preventing internalization of caveolae. J. Cell. Biol. 124:307-13
107. 105. Spector R. 1977. Identification of folate binding macro molecules in rabbit choroid plexus. J. Biol. Chem. 252:3364-70
108. 106. Spector R, Lorenzo AV. 1975. Folate transport by the choroid plexus in vitro. Science 187:540-42
109. 107. Suleiman SA, Spector R. 1981. Purification and characterization of a folate binding protein from porcine choroid plexus. Arch. Biochem. Biophys. 208:87-94
110. 108. Sweiry JH, Yudlievich DL. 1985. Transport of folates at maternal and fetal sides of the placenta: lack of inhibition by methotrexate. Biochim. Biophys. Acta 821:497-501
111. 109. Tolner B, Roy K, Sirotnak FM. 1997. Organization, structure and alternate splicing of the murine RFC-1 gene encoding a folate transporter. Gene 189:1-7
112. 110. Tolner B, Roy K, Sirotnak FM. 1998. Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5′ end heterogeneity. Gene 211:331-41
113. 111. Tolner B, Singh A, Esaki T, Roy K, Sirotnak FM. 1999. Transcription of the mouse rfc-1 gene encoding a folate transporter. Multiplicity and properties of promoters with minimum requirements for their basal activity. Gene. In press
114. 112. Tse A, Brigle K, Taylor SM, Moran RG. 1998. Mutations in the reduced folate carrier gene which confer dominant resistance to 5,10-dideazatetrahydrofolate. J. Biol. Chem. 273:25953-60
115. 113. Underhill TM, Flintoff WF. 1989. Complementation of a methotrexate uptake defect in Chinese hamster ovary cells by DNA-mediated gene transfer. Mol. Cell. Biol. 9:1754-58
116. 114. Underhill TM, Williams FM, Murray RC, Flintoff WF. 1992. Molecular cloning of a gene involved in methotrexate uptake by DNA-mediated gene transfer. Somat. Cell. Mol. Genet. 18:337-49
117. 115. Warren RD, Nichols AP, Bender RA. 1978. Membrane transport of methotrexate in human lymphoblastoid cells. Cancer Res. 38:668-71
118. 116. White JC, Bailey BD, Goldman ID. 1978. Lack of stereospecificity at carbon 6 of methyltetrahydrofolate transport in Ehrlich ascites cell carrier mediated transport of both stereoisomers. J. Biol. Chem. 253:242-45
119. 117. Williams FMR, Flintoff WF. 1995. Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J. Biol. Chem. 270:2987-92
120. 118. Williams FMR, Murray RC, Underhill TM, Flintoff WF. 1994. Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J. Biol. Chem. 269:5810-16
121. 119. Wong SC, Proefke SA, Bhushan A, Matherly LH. 1995. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J. Biol. Chem. 270: 17468-75
122. 120. Wong SC, Zhang L, Proefke SA, Hukku B, Matherly LH. 1998. Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells. Biochem. Pharmacol. 55(7):1135-38
123. 121. Yang C-H, Pain J, Sirotnak FM. 1992. Alteration of folate analogue transport inward after induced maturation of HL-60 leukemia cells. Molecular properties of the transporter in an overproducing variant and evidence for down-regulation of its synthesis in maturating cells. J. Biol. Chem. 267:6628-34
124. 122. Yang C-H, Sirotnak FM, Dembo M. 1983. Relationships between carrier-mediated transport of folate compounds by L1210 leukemia cells. Evidence for multiplicity of entry routes with different kinetic properties expressed membrane vesicles. J. Membr. Biol. 75:11-20
125. 123. Yang C-H, Sirotnak FM, Dembo M. 1984. Interaction between anions and the reduced folate/methotrexate transport system in L1210 cell plasma membrane vesicles: directional symmetry and anion specificity for differential mobility of loaded and unloaded carrier. J. Membr. Biol. 79:285-92
126. 124. Yang C-H, Sirotnak FM, Mines LS. 1988. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of specific transport protein and its partial characterization following affinity labeling. J. Biol. Chem. 263:9703-9
127. 125. Yang-Feng TL, Ma YY, Liang R, Prasad PD, Leibach FH, Ganapathy V. 1995. Assignment of the human folate transporter gene to chromosome 21q22.3 by somatic cell hybrid analysis and in situ hybridization. Biochem. Biophys. Res. Commun. 210(3):874-79
128. 126. Zhang L, Wong SO, Matherly LH. 1998. Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons. Biochem. J. 332:773-80
129. 127. Zhoa R, Assaraf YG, Goldman ID. 1998. A mutated murine reduced folate carrier (RFC-1) with increased affinity for folic acid, decreased affinity for methotrexate, and obligatory anion requirement for transport function. J. Biol. Chem. 273: 19065-71
130. 128. Zhoa R, Asserf YG, Goldman ID. 1998. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservations of growth in 5-formyltetrahydrofolate. J. Biol. Chem. 273:7873-79